Halozyme Therapeutics Inc...

55.79
-0.21 (-0.38%)
At close: Jan 29, 2025, 3:59 PM
55.83
0.07%
After-hours Jan 29, 2025, 04:00 PM EST

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY01
PE Ratio 17.32 38.52 14.04 45.07 -35.42 -26.12 43.89 -12.2 -68.13 -17.32 -20.26 -13.92 -49.34 -14.04 -8.72 -9.19 -22.11 -34.17 -6.9 -8.57 -366.8 -299.53 -128.56
PS Ratio 5.88 11.80 12.76 21.74 13.06 13.82 8.73 8.57 16.26 15.72 30.86 17.61 17.39 54.85 37.23 51.02 139.07 513.38 719.89 n/a 1.13K 222.72 206.51
PB Ratio 58.18 45.86 28.71 38.51 27.89 8.43 13.26 -38.69 51.07 28.63 -84.59 15.26 89.49 36.72 73.72 29.07 9.15 21.84 5.03 5.26 2.88K 225.17 223.21
P/FCF Ratio 13.06 33.09 18.98 109.87 -28.6 -38.75 20.83 -23.48 -55.67 -24.22 -32.75 -11.34 -27.73 -16.23 -12.23 -12.24 -210.27 75.06 -6.86 -9.8 -583.35 -350.47 -148.3
P/OCF Ratio 12.55 32.43 18.89 104.90 -29.96 -42.4 20.62 -24.94 -59.21 -24.92 -34.27 -11.59 -28.4 -16.47 -12.68 -12.64 -3.58K 71.19 -7.05 -10.09 -583.35 -350.47 -148.3
OCF/S Ratio 0.47 0.36 0.68 0.21 -0.44 -0.33 0.42 -0.34 -0.27 -0.63 -0.9 -1.52 -0.61 -3.33 -2.94 -4.04 -0.04 7.21 -102.16 n/a -1.93 -0.64 -1.39
Debt / Equity Ratio 17.89 8.87 4.45 2.63 4.39 0.51 0.97 -6.67 1.16 1.21 -2.49 0.64 n/a n/a n/a n/a n/a n/a n/a n/a n/a 4.61 n/a
Quick Ratio 5.50 4.88 7.45 1.17 6.00 2.71 3.85 4.43 2.60 6.37 3.50 6.77 3.67 5.82 5.09 5.17 11.33 10.62 8.61 10.19 1.27 9.32 7.94
Current Ratio 6.64 5.65 7.91 1.32 6.35 2.86 3.89 4.70 2.75 6.63 3.74 6.92 3.70 5.83 5.17 5.21 11.41 10.73 8.73 10.22 1.27 9.32 7.94
Asset Turnover 0.48 0.36 0.40 0.46 0.35 0.34 0.61 0.56 0.74 0.45 0.54 0.31 0.85 0.15 0.18 0.11 0.04 0.02 0.01 n/a 0.54 0.90 0.94
Interest Coverage 17.99 15.79 36.66 7.08 -5.81 -3.84 3.68 -4.17 -5.28 -11.29 -24.57 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Return on Equity (ROE) 3.36 1.19 2.04 0.85 -0.79 -0.32 0.30 3.17 -0.75 -1.65 4.18 -1.1 -1.81 -2.62 -8.45 -3.16 -0.41 -0.64 -0.73 -0.61 -7.86 -0.75 -1.74
Return on Assets (ROA) 0.16 0.11 0.36 0.22 -0.13 -0.18 0.12 -0.39 -0.18 -0.41 -0.82 -0.4 -0.3 -0.58 -0.76 -0.64 -0.23 -0.32 -0.65 -0.55 -1.66 -0.67 -1.52
Return on Capital (ROIC) 0.21 0.16 0.28 0.91 -0.14 -0.24 0.21 -0.4 -0.23 -0.45 -1.05 -0.46 -0.41 -0.71 -0.93 -0.81 -0.3 -0.37 -0.74 -0.61 -7.86 -0.45 -1.74
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin 76.80% 78.90% 81.64% 83.79% 76.76% 93.33% 90.16% 77.36% 78.35% 69.83% 88.60% 97.41% 99.54% 92.77% 97.72% 96.21% 93.67% 55.49% 59.15% n/a -5.05% 43.40% 35.76%
Net Profit Margin 33.96% 30.62% 90.84% 48.24% -36.86% -52.9% 19.89% -70.23% -23.86% -90.76% -152.33% -126.53% -35.25% -390.79% -426.88% -555.15% -628.93% -1.50K% -10.44K% n/a -307.69% -74.36% -160.63%
Pretax Profit Margin 42.01% 37.71% 56.06% 48.32% -36.86% -52.54% 19.46% -69.44% -23.86% -90.76% -152.33% -126.53% -35.25K% -390.79% -426.88% -555.87% n/a n/a -10.44K% n/a n/a -73.45% -160.63%
Operating Profit Margin 40.71% 40.53% 62.24% 53.91% -34.5% -45.65% 25.58% -56.72% -20.33% -83.68% -146.78% -126.7% -35.37% -398.25% -427.6% -575.47% -740.89% -1.59K% -10.66K% n/a -307.69% -44.88% -160.85%
FCF Margin 45.01% 35.65% 67.22% 19.79% -45.65% -35.67% 41.91% -36.48% -29.2% -64.89% -94.23% -155.33% -62.72% -337.87% -304.35% -416.85% -66.14% 683.96% -10.49K% n/a -193.47% -63.55% -139.25%
EBITDA Margin 54.50% 47.80% 58.43% 57.16% -28.86% -45.65% 26.27% -54.18% -18.77% -81.02% -144.12% -123.97% -33.3% -387.18% -416.32% -563.51% -740.89% -1.48K% -10.50K% n/a -307.69% -16.31% -161.07%